Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016....
Transcript of Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016....
![Page 1: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/1.jpg)
Formularies: Where Do We Go from Here?
Rupali Das, MD, MPH, FACOEM
Sr. Vice President, California Medical Director
Zenith Insurance Company
Roman Kownacki, MD, MPH, FACOEM
Medical Director, Occupational Health - Northern California
Kaiser Permanente
![Page 2: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/2.jpg)
Outline
•Formulary information
•Design
•Predictions
•Recommendations
![Page 3: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/3.jpg)
Formulary: More Than a List of Drugs
Principles of a Sound Drug Formulary System.
Academy of Managed Care Pharmacy, 2000
• Clinical and economic considerations
• Continually updated by experts and evidence-based process
• Aligns with treatment guidelines
• Policies & procedures: dispensing, appropriate utilization, etc.
• Incorporates cost containment strategies
![Page 4: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/4.jpg)
Formularies in Group Health
•Widely Used
•Medicare/MediCal
•Benefit design e.g. Tiers
![Page 5: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/5.jpg)
Formularies – Benefits vs RisksBENEFITS – proven or likely• Improves healthcare delivery
• Lower total drug costs
• Diminished use of inappropriate medications
• Lower UR costs
RISKS - potential• Patients LESS compliant with treatment
• Medical decision may not be patient-focused
• Increased burden for providers
• Increased UR or other administrative costs
![Page 6: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/6.jpg)
Formulary Models
OPEN: a simple and non-exclusive listing of drugs covered
under the drug plan, frequently with various levels of cost-
sharing by the patient for some medications
CLOSED: only listed drugs are covered
HYBRID: in reality, most common model; non-listed drugs
are covered if necessity criteria are met
![Page 7: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/7.jpg)
![Page 8: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/8.jpg)
![Page 9: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/9.jpg)
![Page 10: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/10.jpg)
TEXAS
WORKER’S
COMPENSATION
FORMULARY
Based on ODG
![Page 11: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/11.jpg)
![Page 12: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/12.jpg)
Formulary Evidence Base Format and OrganizationGuidance on medical
conditions? Guidance onpre-authorization?
ODG ODG Guidelines AHFS listing None, except two exclusion types for
certain drugs
Drugs are either YES/NO;
Reed Group ACOEM Practice Guidelines Condition-triggered Yes: general condition, plus ICD-9/10 codes
Drugs are either “Recommended” or “Not recommended,”
Delaware Unstated 3 drug categories, with preferred / non-preferred
drugs
None Drugs are “Preferred” or “Not preferred”; “step care” for non-
preferred drugs
North Dakota Unstated AHFS listing (partial) None Drugs are: “OK, Non-formulary, or Prior Authorization“
Ohio Unstated AHFS listing (partial) None Separate listing of drugs requiring written prior authorization
Washington Unstated 19 drug categories None Drugs are: “OK, Non-formulary, or Prior Authorization“
Features of Existing Workers’ Compensation Formularies
![Page 13: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/13.jpg)
![Page 14: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/14.jpg)
Disputes over Pharmaceutical Treatment Pose Significant Burden
2015 IMR data https://www.dir.ca.gov/dwc/educonf23/UR-IMR/UR-IMR.pdf
![Page 15: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/15.jpg)
Considerations for a state formulary
• Statutory requirements: AB 1124
• Effect of regulations
• Off the shelf or custom-crafted
• Impacts on existing processes and stakeholders
![Page 16: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/16.jpg)
![Page 17: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/17.jpg)
Rx Costs
![Page 18: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/18.jpg)
UR/IMR(Frictional Costs)
![Page 19: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/19.jpg)
Medical Quality
![Page 20: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/20.jpg)
RISKS
![Page 21: Formularies: Where Do We Go from Here?ccwcworkcomp.org/ccwc/assets/File/2016 Conference... · 2016. 8. 1. · Formularies: Where Do We Go from Here? Rupali Das, MD, MPH, FACOEM Sr.](https://reader033.fdocuments.net/reader033/viewer/2022053110/607fba250eff2d2c116cfc27/html5/thumbnails/21.jpg)
RECOMMENDATIONS